Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
1.030
+0.234 (29.35%)
At close: Jun 18, 2025, 4:00 PM
0.9342
-0.0960 (-9.30%)
Pre-market: Jun 20, 2025, 7:37 AM EDT
Biodexa Pharmaceuticals Employees
Biodexa Pharmaceuticals had 13 employees as of December 31, 2024. The number of employees decreased by 8 or -38.10% compared to the previous year.
Employees
13
Change (1Y)
-8
Growth (1Y)
-38.10%
Revenue / Employee
n/a
Profits / Employee
-$551,714
Market Cap
2.98M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
BDRX News
- 2 days ago - Biodexa Hits Key Milestone For Its Type 1 Diabetes Candidate Tolimidone, Enrolls First Patient In Phase 2a Study - Accesswire
- 8 days ago - Result of General Meeting - GlobeNewsWire
- 15 days ago - Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes - GlobeNewsWire
- 20 days ago - Shareholder Update - GlobeNewsWire
- 4 weeks ago - Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Notice of General Meeting - GlobeNewsWire
- 4 weeks ago - Biodexa Announces Award of Additional $3.0M Grant from CPRIT to Support Registrational eRapa Phase 3 Program in FAP Brings Total CPRIT Grant Funding for eRapa Phase 3 Program to $20.0M - GlobeNewsWire
- 5 weeks ago - Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP - GlobeNewsWire
- 2 months ago - Notice of General Meeting - GlobeNewsWire